Weighted Average Number of Shares Outstanding, Basic of CASSAVA SCIENCES INC from 31 Mar 2011 to 31 Dec 2025

Taxonomy & unit: us-gaap: shares
Description: Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary: CASSAVA SCIENCES INC quarterly and annual Weighted Average Number of Shares Outstanding, Basic in shares history and change rate from 31 Mar 2011 to 31 Dec 2025.
CASSAVA SCIENCES INC Weighted Average Number of Shares Outstanding, Basic for the quarter ending 31 Dec 2025 was 48,297,000, a 4.2% increase year-over-year.
CASSAVA SCIENCES INC annual Weighted Average Number of Shares Outstanding, Basic for 2025 was 48,297,000, a 4.2% increase from 2024.
CASSAVA SCIENCES INC annual Weighted Average Number of Shares Outstanding, Basic for 2024 was 46,329,000, a 10% increase from 2023.
CASSAVA SCIENCES INC annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 41,932,000, a 4.3% increase from 2022.
Source SEC data: View on sec.gov

Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)

Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Change (%)

Weighted Average Number of Shares Outstanding, Basic, Annual (shares)

Weighted Average Number of Shares Outstanding, Basic, YoY Annual Change (%)

CASSAVA SCIENCES INC Quarterly Weighted Average Number of Shares Outstanding, Basic (shares)

Period	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed	Fiscal Year	Fiscal Period
Q4 2025	48,297,000	+1,968,000	+4.2%	01 Oct 2025	31 Dec 2025	10-K	12 Mar 2026	2025	FY
Q3 2025	48,308,000	+332,000	+0.69%	01 Jul 2025	30 Sep 2025	10-Q	12 Nov 2025	2025	Q3
Q2 2025	48,308,000	+2,106,000	+4.6%	01 Apr 2025	30 Jun 2025	10-Q	14 Aug 2025	2025	Q2
Q1 2025	48,262,000	+5,261,000	+12%	01 Jan 2025	31 Mar 2025	10-Q	08 May 2025	2025	Q1
Q4 2024	46,329,000	+4,397,000	+10%	01 Oct 2024	31 Dec 2024	10-K	12 Mar 2026	2025	FY
Q3 2024	47,976,000	+5,974,000	+14%	01 Jul 2024	30 Sep 2024	10-Q	12 Nov 2025	2025	Q3
Q2 2024	46,202,000	+4,409,000	+11%	01 Apr 2024	30 Jun 2024	10-Q	14 Aug 2025	2025	Q2
Q1 2024	43,001,000	+1,262,000	+3%	01 Jan 2024	31 Mar 2024	10-Q	08 May 2025	2025	Q1
Q4 2023	41,932,000			01 Oct 2023	31 Dec 2023	10-K	12 Mar 2026	2025	FY
Q3 2023	42,002,000	+1,952,000	+4.9%	01 Jul 2023	30 Sep 2023	10-Q	07 Nov 2024	2024	Q3
Q2 2023	41,793,000	+1,778,000	+4.4%	01 Apr 2023	30 Jun 2023	10-Q	08 Aug 2024	2024	Q2
Q1 2023	41,739,000			01 Jan 2023	31 Mar 2023	10-Q	10 May 2024	2024	Q1
Q3 2022	40,050,000			01 Jul 2022	30 Sep 2022	10-Q	07 Nov 2023	2023	Q3
Q2 2022	40,015,000			01 Apr 2022	30 Jun 2022	10-Q	03 Aug 2023	2023	Q2
Q1 2013	44,932,000	+200,000	+0.45%	01 Jan 2013	31 Mar 2013	10-Q	24 Apr 2013	2013	Q1
Q1 2012	44,732,000	+1,608,000	+3.7%	01 Jan 2012	31 Mar 2012	10-Q	24 Apr 2013	2013	Q1
Q1 2011	43,124,000			01 Jan 2011	31 Mar 2011	10-Q	08 May 2012	2012	Q1

Period	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed	Fiscal Year	Fiscal Period
2025	48,297,000	+1,968,000	+4.2%	01 Jan 2025	31 Dec 2025	10-K	12 Mar 2026	2025	FY
2024	46,329,000	+4,397,000	+10%	01 Jan 2024	31 Dec 2024	10-K	12 Mar 2026	2025	FY
2023	41,932,000	+1,730,000	+4.3%	01 Jan 2023	31 Dec 2023	10-K	12 Mar 2026	2025	FY
2022	40,202,000	+797,000	+2%	01 Jan 2022	31 Dec 2022	10-K	03 Mar 2025	2024	FY
2021	39,405,000			01 Jan 2021	31 Dec 2021	10-K	28 Feb 2024	2023	FY
2015	45,756,000	+487,000	+1.1%	01 Jan 2015	31 Dec 2015	10-K	03 Mar 2016	2015	FY
2014	45,269,000	+262,000	+0.58%	01 Jan 2014	31 Dec 2014	10-K	03 Mar 2016	2015	FY
2013	45,007,000	+254,000	+0.57%	01 Jan 2013	31 Dec 2013	10-K	03 Mar 2016	2015	FY
2012	44,753,000	+593,000	+1.3%	01 Jan 2012	31 Dec 2012	10-K	18 Feb 2015	2014	FY
2011	44,160,000			01 Jan 2011	31 Dec 2011	10-K	05 Feb 2014	2013	FY

* An asterisk sign (*) next to the value indicates that the value is likely invalid.